PUBLIC HEALTH, NURSING AND MEDICAL SOCIAL WORK

PEDIATRICS ◽  
1953 ◽  
Vol 11 (3) ◽  
pp. 290-293

STANDARDIZATION of terminology for drugs and scientific substances appears to be a highly desirable goal. Exchange of information through publication and individual communication would be far less subject to misinterpretation if nomenclature were precise and unchanged. Furthermore, increase in world travel makes it more necessary than ever that patients, physicians, and pharmacists be able severally to request and comply with requests for drugs without worry about differences in names. International health co-operation and regional health program would obviously benefit from simplification of terminology. The situation has recently been reviewed by P. Blanc, Secretary of the World Health Organization Expert Committee on the International Pharmacopoeia, before the International Pharmaceutical Federation. His paper has been summarized in the Chronicle of the World Health Organization, for November 1952, volume 6, page 322, from which the following extracts are taken: "At first sight it might seem that, for the numerous drugs which are chemical compounds, the chemical names could be used; but the latter are often so complicated that manufacturers and sales agents spontaneously adopt simpler and shorter names. Obviously `riboflavine' sounds better and is more easily remembered than 6:7-dimethyl-9-(D-1'-ribityl)izo-alloxazine. But, unfortunately, the same substance is known elsewhere by the name of `lactoflavine' or `vitamin B2'. Another example may be cited, namely that of the methadone hydrochloride of the Pharmacopoea Internationalis (6-dimethylamino-4,4-diphenyl-3-heptanone), which is known in different countries under the following names: amidone, miadone, diadone, diaminon, mephenon, symoron, etc.

PEDIATRICS ◽  
1951 ◽  
Vol 8 (4) ◽  
pp. 570-572

IN THE summary of the report of the Expert Committee on Prematurity of the World Health Organization, published in this column in February 1951, Dr. Ethel Dunham indicated the concern of the Expert Committee in regard to uniformity of information on the incidence and mortality of prematurity. The need for uniformity is particularly urgent in a field where there are so many intrinsic variable factors. It has been shown time and again that the ability of a premature infant to survive, under the best of care, is closely correlated with the birth weight, which in itself reflects the stage of maturity. In turn, the stage of maturity at a given weight is affected by sex, race, and whether the child is a single or one of a multiple birth. Uniformly, at a particular stage of maturity, male infants are larger than female, single births are larger than multiple births and, in the United States, white babies are larger than Negro babies. These considerations underline the danger of misinterpretation of so-called over-all rates for the incidence of prematurity and for the mortality of premature infants. For example, at any given weight, Negro premature infants are probably more mature and consequently have a better chance of surviving.


PEDIATRICS ◽  
1966 ◽  
Vol 37 (2) ◽  
pp. 392-392
Author(s):  
THOMAS E. CONE

This is a timely, concise, eminently practical, thoughtfully, even tenderly, written 28 page report of a recent WHO Expert Committee meeting on the health problems of adolescence. The members and the consultants to the Committee deftly summarize the major worldwide trends affecting our adolescent population. The size of this population is staggering; in the age group 15-19 years alone there are already 300 million adolescents in the world, and there seems every likelihood that these numbers will increase rapidly during the next decade.


2021 ◽  
pp. 172-180
Author(s):  
Fitrio Deviantony ◽  
Grysha Viofananda ◽  
Nurul Hidayah ◽  
Nadhifa Eriyanti

permasalahan serius di dunia dan Indonesia. Data dari World Health Organization sekitar 21 juta orang mengalami skizofrenia. Prevalensi skizofrenia di Indonesia mengalami peningkatan proporsi per 1000 penduduk (1,7%) pada tahun 2013 menjadi (7%) pada tahun 2018. Faktanya terapi keperawatan untuk halusinasi belum optimal sedangkan teknologi terus berkembang seperti Virtual Reality (VR). VR mampu menurunkan gejala pada skizofrenia dengan kemampuan membuat perilaku interaktif dan tersimpan dalam otak agar tidak menimbulkan halusinasi. Teknologi ini digunakan untuk mengetahui manfaat E-Health Nursing VR sebagai terapi halusinasi pada pasien skizofrenia. Metode penelitian menggunakan systematic review dari 5 database yaitu Nature, Frontiers, BMC, Science Direct, NEJM sehingga didapat total 55 literatur. Mayoritas 63% mengulas terapi VR untuk mengurangi halusinasi pada skizofrenia. Perkembangan manfaat VR diverifikasi dalam beberapa pengobatan: skizofrenia, PTSD, kecemasan, akrofobia, ganguan citra tubuh, claustrophobia, dan lain-lain. Beberapa studi skizofrenia menyatakan terapi VR sangat efektif menangani delusi, halusinasi, gejala kepribadian skizoid. VR juga berguna dalam rehabilitas kognitif pada orang dewasa atau anak-anak autis dalam keterampilan dan kemandirian. Kesimpulan penelitian ini adalah VR terbukti efektif sebagai terapi kesehatan jiwa di masa mendatang. Disisi lain terdapat terapi psikologis pilihan seperti terapi perilaku kognitif, dan psikoterapi interpersonal. Oleh karenanya diperlukan kombinasi terapi VR dengan terapi komplementer tersebut dalam mengurangi halusinasi pada skizofrenia.   Mental health become a severe problem in the world and Indonesia. Data from the World Health Organization (WHO, 2016) estimated that 21 million people have schizophrenia. The prevalence of schizophrenia in Indonesia has increased proportion per 1000 population (1,7%) in 2013 to (7%) in 2018. In fact of nursing, therapy for hallucination is not optimal while constantly evolving technology such as Virtual Reality (VR). VR can reduce symptoms in schizophrenia with the ability to create interactive behavior and stored in the brain in order to cause hallucinations. The objective of this study was to review the benefit of VR as a hallucination therapy in schizophrenia patients. This research used a systematic literature review from five databases Nature, Frontiers, BMC, Science Direct, NEJM, and resulted in the retrieval of 55 papers. The majority of a result found a 63% review in Virtual Reality therapy can reduce hallucination in schizophrenia. VR is a technology browser and manipulator sensory environment in real-time 3D. The progressing benefit of VR verified in the treatment of schizophrenia, PSTD, anxiety, acrophobia, body image disorder, claustrophobia, and others. Some studies of schizophrenia declare that virtual reality therapy is effective in treating delusions, hallucinations, and a symptom of schizoid behavior. VR also has benefits in cognitive rehabilitation in adults or children with autism's inability and self-reliance. VR has a bright future as the treatment of mental health. The progressing of technology and research has an excellent opportunity for VR to reduce schizophrenia. Moreover, there is psychological therapy, such as cognitive-behavioral therapy and interpersonal psychotherapy. Therefore a combination needed of virtual therapy with the complementary therapy for reducing hallucination in schizophrenia.


2014 ◽  
Vol 18 (1) ◽  
pp. 405-424
Author(s):  
Pia Acconci

The World Health Organization (who) was established in 1946 as a specialized agency of the United Nations (un). Since its establishment, the who has managed outbreaks of infectious diseases from a regulatory, as well as an operational perspective. The adoption of the International Health Regulations (ihrs) has been an important achievement from the former perspective. When the Ebola epidemic intensified in 2014, the who Director General issued temporary recommendations under the ihrs in order to reduce the spread of the disease and minimize cross-border barriers to international trade. The un Secretary General and then the Security Council and the General Assembly have also taken action against the Ebola epidemic. In particular, the Security Council adopted a resolution under Chapter vii of the un Charter, and thus connected the maintenance of the international peace and security to the health and social emergency. After dealing with the role of the who as a guide and coordinator of the reaction to epidemics, this article shows how the action by the Security Council against the Ebola epidemic impacts on the who ‘authority’ for the protection of health.


2020 ◽  
Vol 3 (1) ◽  
pp. 10-27
Author(s):  
Yen-Fu Chen

Despite being one of Asia’s major economies with a population of over 23 million, Taiwan has been mostly excluded from the World Health Assembly/World Health Organization (wha/who) since 1972, due to China’s objection. While this has not stopped Taiwan from developing a comprehensive healthcare system and being an active member of international health community, the lack of membership in the world’s leading health authority undermines global health and presents perverse, and yet often neglected, inequality faced by Taiwanese people. This article aims to provide contextual information concerning the impacts of Taiwan’s exclusion from wha/who by: (1) enumerating health-related areas where Taiwan has rich knowledge and experiences that would have been cascaded much more widely and efficiently to those in need around the world had it been allowed to participate; and (2) highlighting difficulties faced by Taiwanese people and potential threats to international health arising from the exclusion.


2021 ◽  
Vol 60 (91) ◽  
pp. 271-286
Author(s):  
Jovana Blešić

The World Health Organization (WHO) is one of the UN specialized agencies. Its work and functions gained even more importance in 2020 with the emergence of the corona virus. The eyes of the entire international community focused on this organization and its Director General. Nowadays, its efficiency has been subject to various forms of criticism. In this paper, the author first provides a brief overview of this organization and its significance. The central part of the paper focuses on the activities of the WHO during the Covid-19 pandemic, through the clarification of the concept of public health emergency of international concern and the use of International Health Regulations. Finally, the author discusses the possible reform of this body. The aim of this paper is to familiarize the readers with the World Health Organization and put its activities in the context of the ongoing Covid-19 pandemic.


Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Shaima S. Ali Miraj

Introduction: Of late several articles in prestigious scientific platforms have shown that, 'COVID-19 has questioned the global health expertise of some developed countries like the USA UK and other European nations as well as the international health agency, the World Health Organization, highlighting that they faltered in managing the crisis during the pandemic. The objective of this article is to highlight the fact that as there was no specific vaccine or treatment at hand, the portfolio available with these nations under the directions of the WHO to counter the measures against COVID19, was limited. There was no other alternative in this time of world’s most unprecedented emergency, and whatever immediate steps were taken to contain the virus spread by the WHO were justified. Methods: Using the available literature on the internet and library sources, a survey of published articles in leading journals of the world have been made to analyse the various articles describing the position of the WHO and its future strategies in dealing with the worlds most unprecedented pandemic. Results and Conclusion: The present communication suggests that a large scale fund allocation in a fixed percentage for Health for All, from every member country’s defence budget can be separately made for substantially replenishing the already depleting funding of the WHO. This will enable an effective control of the global pandemic crisis with significant international cooperation, allowing sharing of the financial burden. The specially created fund can be used under international monitoring for such unprecedented calamities in future. More focus can thus be given to special training of manpower, advancements in the protective equipment, development of vaccines, critical care hospitals and centres on a global basis.


PEDIATRICS ◽  
1950 ◽  
Vol 6 (5) ◽  
pp. 785-788

EVERY practicing pediatrician is faced with the problem of possible rabies in children bitten by animals. This terrifying and dramatic disease, of world-wide distribution and concern, has been the object of research in many countries. Following an International Rabies Conference in Paris in 1927, data concerning 1,600,000 persons treated were collected by the Health Organization of the League of Nations. Final proof of the value of Pasteur treatment could not, however, be obtained, as no evidence was available to compare the outcome of the disease in treated and untreated individuals. After discussion at the First World Health Assembly in 1948 rabiologists all over the world were consulted by the World Health Organization through a questionnaire, and an expert committee was convened in Geneva from 17 to 22 April, 1950, to examine the replies received, review the newest developments, and make recommendations. Highlights of the report of this Expert Committee are presented in the Chronicle of the World Health Organization, vol.4, no.9, pp. 278-284, September 1950. Active Immunization Since Pasteur first used his vaccine in attempts at therapy major activity has been directed at two objectives—treatment of the exposed human beings and mass immunization of animals. "Differences which are known to exist in the biological quality of antirabies vaccines have thrown doubt on the value of current vaccination procedures.


Sign in / Sign up

Export Citation Format

Share Document